Prof. Hani Gabra, MD

Prof. Hani Gabra, MD is a distinguished medical oncologist and researcher with extensive experience in cancer research and drug development. He currently holds several prominent positions: Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust Professor Emeritus in Medical Oncology at Imperial College London Co-Founder, Board Member, and Chief Scientific Officer at Papyrus Therapeutics Inc. Prof. Gabra's expertise lies in gynaecological oncology, particularly ovarian cancer, as well as tumor suppressor genes and receptor tyrosine kinase networks. His research focuses on the molecular basis of clinical platinum resistance and translational research in early-phase clinical trials. Throughout his career, Prof. Gabra has been involved in significant advancements in cancer treatment and research. He has played key roles in leading research centers and pharmaceutical companies, driving innovation in oncology drug development. As a leading figure in the field of oncology, Prof. Gabra continues to contribute to the development of new cancer therapies and treatments. His work supports the advancement of personalized medicine approaches and the optimization of clinical trials in oncology.